| Literature DB >> 20395292 |
Elisa Vilardo1, Christian Barbato, Mariateresa Ciotti, Carlo Cogoni, Francesca Ruberti.
Abstract
The amyloid precursor protein (APP) and its proteolytic product amyloid beta (Abeta) are associated with both familial and sporadic forms of Alzheimer disease (AD). Aberrant expression and function of microRNAs has been observed in AD. Here, we show that in rat hippocampal neurons cultured in vitro, the down-regulation of Argonaute-2, a key component of the RNA-induced silencing complex, produced an increase in APP levels. Using site-directed mutagenesis, a microRNA responsive element (RE) for miR-101 was identified in the 3'-untranslated region (UTR) of APP. The inhibition of endogenous miR-101 increased APP levels, whereas lentiviral-mediated miR-101 overexpression significantly reduced APP and Abeta load in hippocampal neurons. In addition, miR-101 contributed to the regulation of APP in response to the proinflammatory cytokine interleukin-1beta (IL-lbeta). Thus, miR-101 is a negative regulator of APP expression and affects the accumulation of Abeta, suggesting a possible role for miR-101 in neuropathological conditions.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20395292 PMCID: PMC2881760 DOI: 10.1074/jbc.M110.112664
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157